![David Jorden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Jorden
Amministratore Delegato presso
NUO THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/08/2026
Profilo
Mr. David E.
Jorden, CFA MBA, is a Chief Executive Officer & Director at Nanospectra Biosciences, Inc. and a CEO, CFO, Secretary & Director at Nuo Therapeutics, Inc. He is on the Board of Directors at Nanospectra Biosciences, Inc. and Nuo Therapeutics, Inc. Mr. Jorden was previously employed as a Chief Financial Officer by PLx Pharma, Inc., a Vice President by Morgan Stanley, a Chief Financial Officer & Vice President by Genometrix, Inc., a Principal by Fayez Sarofim & Co. LLC, and a Chief Financial Officer & Director by PLx Pharma, Inc. /Old/.
He also served on the board at Opexa Therapeutics, Inc. He received his undergraduate degree from The University of Texas at Austin and an MBA from Kellogg School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
NUO THERAPEUTICS INC 4,27% | 28/08/2026 | 2.070.000 ( 4,27% ) | 2 M $ | 31/08/2026 |
Posizioni attive di David Jorden
| Società | Posizione | Inizio |
|---|---|---|
| NUO THERAPEUTICS, INC. | Amministratore Delegato | 08/01/2016 |
Nanospectra Biosciences, Inc.
 Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic products | Amministratore Delegato | 01/06/2013 |
Precedenti posizioni note di David Jorden
| Società | Posizione | Fine |
|---|---|---|
| PLX PHARMA WINDDOWN CORP. | Direttore Finanziario/CFO | 01/07/2017 |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Direttore Finanziario/CFO | 02/04/2013 |
| MORGAN STANLEY | Corporate Officer/Principal | - |
Genometrix, Inc.
 Genometrix, Inc. Miscellaneous Commercial ServicesCommercial Services Performs commercial physical and biological research | Direttore Finanziario/CFO | 01/09/2002 |
Fayez Sarofim & Co. LLC
 Fayez Sarofim & Co. LLC Investment ManagersFinance FSC is a long-term investor which seeks to generate sustainable earnings growth by dominantly investing in large-cap companies. The firm employs a predominantly bottom-up investment decision-making process managed by the Investment Committee. The committee formulates a macroeconomic and capital market outlook and evaluates the attractiveness of the various economic sectors and industries. | Corporate Officer/Principal | - |
Formazione di David Jorden
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
97
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Morgan Stanley
 Morgan Stanley Investment ManagersFinance Provides wealth and asset management, trading & investment banking services | Finance |
Fayez Sarofim & Co. LLC
Fayez Sarofim & Co. LLC Investment ManagersFinance FSC is a long-term investor which seeks to generate sustainable earnings growth by dominantly investing in large-cap companies. The firm employs a predominantly bottom-up investment decision-making process managed by the Investment Committee. The committee formulates a macroeconomic and capital market outlook and evaluates the attractiveness of the various economic sectors and industries. | Finance |
Nuo Therapeutics, Inc.
 Nuo Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops drugs for the treatment of chronic wounds | Health Technology |
Genometrix, Inc.
Genometrix, Inc. Miscellaneous Commercial ServicesCommercial Services Performs commercial physical and biological research | Commercial Services |
PLx Pharma, Inc. /Old/
 PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology Develops formulations of non steroidal anti-inflammatory drugs | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanospectra Biosciences, Inc.
Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic products | Health Technology |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PLx Pharma, Inc.
 PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops liquid-filled aspirin capsules for pain management | Health Technology |
